Growth in 3D Printing Medical Devices market is primarily driven by technological advancements towards the development of biocompatible materials; increased funding, research grants, and public-private investments; and growing government initiatives to improve healthcare infrastructure of hospitals

[497 Pages Report] The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911

Report Scope and Market Segmentation:

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2022–2026

Forecast Units

Value (USD Billion)

Segments Covered

Component, Application, Technology, End User, and Region

Geographies Covered

North America, Europe, APAC, Latin America and Middle East & Africa

Companies Covered

Stratasys Ltd. (US & Israel), 3D Systems Corporation (US), GE Additive (US), Materialise NV (Belgium), Renishaw plc (UK), SLM Solutions Group AG (Germany), Desktop Metal, Inc. (US), Prodways Group (France), Carbon, Inc. (US), CELLINK (Sweden), Organovo Holdings, Inc. (US), EOS (Electro Optical Systems) GmbH (Germany), Biomedical Modeling, Inc. (US), Formlabs, Inc. (US), 3T Additive Manufacturing Ltd. (UK), DENTSPLY Sirona, Inc. (US), DWS Systems SRL (Italy), Roland DG (Japan), HP, Inc. (US), and regenHU (Switzerland)



Based on application, the custom prosthetics and implants segment is expected to account for the largest share of the 3D Printing Medical Devices market

Based on application, the 3D Printing Medical Devices market has been segmented into surgical guides, surgical instruments, standard prosthetics and implants, custom prosthetics and implants, tissue-engineered products, hearing aids, wearable medical devices/implantable medical devices, and other medical devices.

The external power supply segment is expected to register the highest growth rate during the forecast period

Based on technology, the 3D Printing Medical Devices market has been segmented into electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and other technologies.

North America is expected to dominate the global 3D Printing Medical Devices market

North America, comprising the US and Canada, accounted for the largest share of the 3D Printing Medical Devices market in 2020. Increasing number of vendors manufacturing 3D Printing Medical Devices and a growing number of approvals for 3D Printing Medical Devices are the major factors driving market growth in North America.

Stratasys Ltd. (US) has a wide range of product offerings in the 3D Printing Medical Devices market, including equipments, materials, software and services. The company sustains its key position in the global 3D printing medical devices market owing to its multiple strategic acquisition Stratasys Ltd.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=90799911